Precision Medicine News and Research

RSS

Researchers create experimental blood test that determines BHI by gauging performance of mitochondria

Researchers at the University of Alabama at Birmingham School of Medicine have created an experimental blood test that, for the first time, determines a "Bioenergetic Health Index," or BHI, by gauging the performance of mitochondria, the cell's energy powerhouses.

30 May 2014

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death. Used with other indicators such as biochemical markers and family history, the profile - based on a simple blood test - may help identify patients who could benefit from personalized treatment and counseling designed to address risk factors.

30 May 2014

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).

28 May 2014

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company's semiconductor-based synthetic gene manufacturing process.

27 May 2014

Immucor's PreciseType HEA test receives FDA approval to predict blood compatibility

Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced that the U.S. Food and Drug Administration has granted approval for the company's PreciseType HEA test.

23 May 2014

Researchers identify mutation in fat-storage gene that appears to increase risk for type 2 diabetes

Researchers at the University of Maryland School of Medicine have identified a mutation in a fat-storage gene that appears to increase the risk for type 2 diabetes and other metabolic disorders, according to a study published online today in the New England Journal of Medicine.

23 May 2014

Researchers use computer simulations to identify drugs most likely to kill cancer cells

Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells - cancer avatars - to identify drugs most likely to kill cancer cells isolated from patients' brain tumors.

22 May 2014

$Fracture liaison service reduces risk of fragility fractures in older adults$

Fracture liaison service reduces risk of fragility fractures in older adults

Studies have shown that anyone age 50 or older who suffers a fragility fracture – a bone break sustained in a fall from a standing height or less – is two to five times more likely to experience a second fracture than someone who hasn't had one. The odds that a person who's suffered two such fractures will have a third are even higher.

17 May 2014

Viewpoints: GOP attacks on health law; challenging assumptions about Obamacare politics; is employer mandate worth it?

A crucial component of the Republican Party's assault on the Affordable Care Act always has been ignorance -- that is, the promotion of ignorance about the ACA's benefits among the general population. Now, from the consulting firm McKinsey & Co., comes hard evidence that the campaign worked, bigtime. In its latest national survey to determine how the healthcare reform act has been working, McKinsey found that the perceived cost of health insurance still was the No. 1 reason given by respondents for not enrolling (Michael Hiltzik, 5/14).

16 May 2014

Researchers test genomic sequencing for women with triple negative breast cancer

Indiana University cancer researchers are testing whether therapy incorporating advanced genomic technology will provide better outcomes than current treatments for those with an aggressive form of breast cancer.

15 May 2014

Virtualscopics reports record revenues in first quarter 2014

VirtualScopics, Inc., a leading provider of quantitative imaging solutions, today reported the financial results for the first quarter ended March 31, 2014.

15 May 2014

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

A novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis (PVNS), a rare neoplastic joint disorder, according to new phase I data from Memorial Sloan Kettering Cancer Center and other institutions highlighted to media today in advance of the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will take place from May 30 to June 3 in Chicago.

15 May 2014

Precision Medicine News and Research

Researchers create experimental blood test that determines BHI by gauging performance of mitochondria

Blood gene expression profile identifies patients with elevated risk of cardiovascular death

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Immucor's PreciseType HEA test receives FDA approval to predict blood compatibility

Researchers identify mutation in fat-storage gene that appears to increase risk for type 2 diabetes

Researchers use computer simulations to identify drugs most likely to kill cancer cells

Fracture liaison service reduces risk of fragility fractures in older adults

Viewpoints: GOP attacks on health law; challenging assumptions about Obamacare politics; is employer mandate worth it?

Researchers test genomic sequencing for women with triple negative breast cancer

Virtualscopics reports record revenues in first quarter 2014

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

NSHOA and Caris Life Sciences collaborate to establish personalized cancer care program

Luminex announces group B strep as fifth assay planned for launch menu of ARIES

FLUIDDA's breakthrough imaging technology helps optimize COPD treatment

Flatiron Health agrees to acquire Altos Solutions

Leica and Affymetrix launch fully automated RNA in situ hybridization assays

Molecular subtyping provides insights into how to treat breast cancer

TGen/George Mason create strategic research alliance to benefit patients with cancer, life-threatening illnesses

iQBS researchers develop new gene expression analysis approach for identifying cancer genes

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News